In order to increase efficiency of treatment of the patients suffering from renal cancer, method of endolymphatic chemotherapy is developed and introduced in practice. The direct and remote results of palliative chemotherapy in 115 patients are presented. The developed method has allowed in the basic group with sharp decrease in system toxic effects to reach one-year survival rate in (86.8±7.3)% of patients, two-year — in (79.2±10.7)%, three-year — in (71.4±12.8)%, four-year — in (67.3±12.2)%, five-year — in (60.7±13.1)%.
